Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 Diabetes
研究概览
地位
条件
详细说明
Arteriograph24 is a new monitor for measuring ambulatory blood pressure and additional performing brachial cuff based on analysis of a suprasystolic pulse wave.
The study aim to test the feasibility of ambulatory pulse wave analysis every twenty minute (the fraction of missed measurements)and the reprodicility of pulse wave velocity and central augmentation index in type 2 diabetic patients. In addition we will explore the relation between diurnal variation of brachial blood pressure, central blood pressure and pulse wave velocity.
20 type 2 diabetic patients will have 24h ambulatory blood pressure performed twice with an interval of one week.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Silkeborg、丹麦、8600
- Medical department, Diagnostic Center, Regional Hospital Silkeborg
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Type 2 diabetes
Exclusion Criteria:
- Atrial fibrillation
学习计划
研究是如何设计的？
设计细节
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Fraction of missed pulse wave analysis
大体时间：Meaured two times with an interval of one week
|
Measurements of ambulatory blood pressure and pulse wave analysis is performed every twenty minute.
The fraction of missed measurements of pulse wave analysis during day time and night time analysis is the final outcome
|
Meaured two times with an interval of one week
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Reproducibility of pulse wave analysis parameters
大体时间：Measured two times with an interval of one week
|
Reproducibility of pulse wave velocity, Central systolic blood pressure and central augmentation index for 24 hour, day and night
|
Measured two times with an interval of one week
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Diurnal variation of brachial blood pressure, central blood pressure and pulse wave velocity
大体时间：Measured two times with an interval of one week
|
brachial blood pressure, central blood pressure and pulse wava velocity is measured evrey twenty minutes and averaged for day time and night time.
the relative reduction at nioght for the parameters are calculated
|
Measured two times with an interval of one week
|
合作者和调查者
调查人员
- 首席研究员：Klavs W Hansen, MD, dr.med.、Medical department, Diagnostic Center, Regional Hospital Silkeborg, Denmark
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
2型糖尿病的临床试验
-
Jin-Hee AhnAsan Medical Center未知HER-2基因扩增 | HER-2 蛋白过表达
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.主动，不招人
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological Pharmaceutical Co...主动，不招人
-
University Hospital Inselspital, BerneUniversity of Bern; Lucerne University of Applied Sciences and Arts完全的